Shivani Chawla-Mehta, MD
Family Practice · Milpitas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 37
- 11 carriers
- Office
- 1
Offices
1 location
Looking this up.
Plans that list them
37 plans · 11 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chawla-Mehta’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
37 of 37 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A123387 · Current
Licensed to practise in California · since 2012 · expires 2028-07-31 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$11,259
Medicare paid this office $11,259 for 24 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 18 | $5,101 | $113 |
| Short return visit (20+ min) | 12 | $1,603 | $84 |
Procedures Medicare counted
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
24 Original Medicare patients in 2024. Average age 71 · Also on Medicaid 54% · Health risk score 1.32. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 67%.
The office billed $19,126, Medicare allowed $14,211 and paid $11,259; for 114 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 24 | 114 | 71 | 1.32 | $19,126 | $11,259 |
| 2023 | 16 | 93 | 70 | 0.93 | $13,614 | $7,779 |
| 2022 | 11 | 81 | 68 | 0.83 | $10,152 | $5,743 |
| 2021 | 134 | 301 | 74 | 1.23 | $49,583 | $16,036 |
| 2020 | 98 | 531 | 75 | 1.15 | $36,372 | $9,274 |
| 2019 | 61 | 116 | 73 | 0.95 | $19,645 | $5,862 |
| 2016 | 50 | 99 | 79 | 1.36 | $10,081 | $1,075 |
| 2015 | 364 | 853 | 72 | 1.16 | $77,649 | $24,738 |
| 2014 | 471 | 980 | 76 | 1.19 | $94,552 | $36,548 |
| 2013 | 159 | 512 | 71 | 0.98 | $40,614 | $15,201 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Return visit (30+ min) | 12 | $4,296 | $110 |
2021: 7 services
| Return visit (30+ min) | 72 | $8,640 | $115 |
| Short return visit (20+ min) | 44 | $3,710 | $82 |
| Long return visit (40+ min) | 15 | $1,931 | $129 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 17 | $872 | $51 |
| Injection of drug or substance under skin or into muscle | 18 | $251 | $13 |
| Automated urinalysis test | 17 | $38 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 12 | $21 | None |
2020: 4 services
| Return visit (30+ min) | 63 | $5,818 | $92 |
| Short return visit (20+ min) | 30 | $1,771 | $59 |
| Injection of drug or substance under skin or into muscle | 15 | $221 | $13 |
| Automated urinalysis test | 14 | $31 | $2 |
2019: 2 services
| Return visit (30+ min) | 34 | $3,468 | $102 |
| Short return visit (20+ min) | 26 | $1,844 | $71 |
2016: 1 service
| Short return visit (20+ min) | 40 | $428 | $11 |
2015: 10 services
| Short return visit (20+ min) | 332 | $18,828 | $53 |
| Return visit (30+ min) | 27 | $2,365 | $88 |
| Injection of drug or substance under skin or into muscle | 31 | $719 | $22 |
| Inhalation treatment for airway obstruction or sputum production | 43 | $530 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 27 | $390 | $14 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 23 | $272 | $12 |
| Urinalysis, manual test | 54 | $177 | $3 |
| Injection, ketorolac tromethamine, per 15 mg | 18 | $33 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 36 | $4 | None |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 11 | $1 | None |
2014: 10 services
| Short return visit (20+ min) | 390 | $26,119 | $62 |
| Return visit (30+ min) | 73 | $6,892 | $94 |
| Injection of drug or substance under skin or into muscle | 38 | $848 | $22 |
| Inhalation treatment for airway obstruction or sputum production | 43 | $765 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 23 | $335 | $15 |
| Urinalysis, manual test | 24 | $82 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 17 | $33 | None |
| Injection, ketorolac tromethamine, per 15 mg | 15 | $15 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 34 | $5 | None |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 11 | $2 | None |
2013: 10 services
| Return visit (30+ min) | 86 | $7,679 | $80 |
| Short return visit (20+ min) | 54 | $3,251 | $52 |
| Injection of drug or substance under skin or into muscle | 16 | $367 | $20 |
| Blood test, lipids (cholesterol and triglycerides) | 17 | $262 | $15 |
| Blood test, comprehensive group of blood chemicals | 19 | $222 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $191 | $15 |
| Hemoglobin a1c level | 11 | $157 | $13 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 14 | $147 | $10 |
| Insertion of needle into vein for collection of blood sample | 38 | $118 | $3 |
| Automated urinalysis test | 18 | $55 | $3 |
Medicaid work
$64 in 2024
Medicaid paid $64 for 392 billed services this clinician did in 2024, up to 29 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 282 | $38 |
| Short return visit (20+ min) | 65 | $26 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 45 | $0 |
| 2024 | 392 | 3 | 29 | $64 |
| 2023 | 89 | 1 | 15 | $0 |
| 2022 | 64 | 1 | 32 | $0 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 89 | $0 |
2022
| Return visit (30+ min) | 64 | $0 |
Drugs they prescribed that Part D paid
$65,650
Pharmacies billed $65,650 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
552 generic and fewer than 11 brand-name prescriptions · $65,650 in drug cost · 18 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 70 | $797 | $11 |
| Albuterol Sulfate Hfa | 12 | $378 | $32 |
| Gabapentin | 17 | $340 | $20 |
| Tamsulosin | 16 | $269 | $17 |
| Meloxicam | 23 | $203 | $9 |
See all 14 drugs
| Atorvastatin | 70 | $797 | $11 |
| Albuterol Sulfate Hfa | 12 | $378 | $32 |
| Gabapentin | 17 | $340 | $20 |
| Tamsulosin | 16 | $269 | $17 |
| Meloxicam | 23 | $203 | $9 |
| Ondansetron | 11 | $178 | $16 |
| Amlodipine Besylate | 32 | $170 | $5 |
| Simvastatin | 18 | $145 | $8 |
| Metformin | 17 | $120 | $7 |
| Trazodone | 16 | $118 | $7 |
| Lisinopril | 12 | $68 | $6 |
| Losartan | 12 | $57 | $5 |
| Propranolol | 11 | $38 | $3 |
| Hydrochlorothiazide | 11 | $6 | $1 |
Year by year
| 2024 | 632 | 60 | None | None | $65,650 |
| 2023 | 268 | 34 | 0% (0) | 9% | $32,338 |
| 2022 | 43 | None | 0% (0) | None | $8,718 |
| 2021 | 118 | 75 | None | None | $3,375 |
| 2020 | 70 | 53 | None | None | $1,366 |
| 2019 | 74 | 51 | None | None | $2,674 |
| 2018 | 370 | 133 | 0% (0) | None | $14,065 |
| 2017 | 1,893 | 296 | 3% (48) | 18% | $86,256 |
| 2016 | 420 | 160 | 12% (52) | None | $23,677 |
| 2015 | 549 | 312 | 3% (18) | None | $15,054 |
| 2014 | 809 | 434 | 4% (33) | None | $23,904 |
| 2013 | 880 | 263 | 2% (18) | None | $31,629 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Atorvastatin | 31 | $438 | $14 |
| Tamsulosin | 12 | $318 | $26 |
| Simvastatin | 11 | $216 | $20 |
2021: 2 drugs
| Cephalexin | 11 | $70 | $6 |
| Prednisone | 12 | $45 | $4 |
2020: 1 drug
| Cephalexin | 12 | $60 | $5 |
2018: 10 drugs
| Atorvastatin | 53 | $1,408 | $27 |
| Levothyroxine | 17 | $509 | $30 |
| Losartan | 18 | $508 | $28 |
| Ranitidine | 11 | $283 | $26 |
| Lisinopril | 20 | $253 | $13 |
| Simvastatin | 17 | $187 | $11 |
| Metformin | 15 | $164 | $11 |
| Glipizide | 11 | $148 | $13 |
| Fluticasone Propionate | 11 | $140 | $13 |
| Amlodipine Besylate | 13 | $112 | $9 |
2017: 46 drugs
| Atorvastatin | 125 | $3,437 | $27 |
| Levothyroxine | 68 | $2,399 | $35 |
| Fentanyl | 14 | $2,270 | $162 |
| Losartan | 62 | $1,811 | $29 |
| Diclofenac | 19 | $1,531 | $81 |
| Ventolin Hfa | 35 | $1,468 | $42 |
| Propranolol | 11 | $1,270 | $115 |
| Duloxetine | 27 | $966 | $36 |
| Lisinopril | 74 | $885 | $12 |
| Simvastatin | 62 | $859 | $14 |
| Gabapentin | 21 | $828 | $39 |
| Meloxicam | 78 | $694 | $9 |
| Metformin | 54 | $645 | $12 |
| Pantoprazole | 22 | $644 | $29 |
| Glipizide | 45 | $632 | $14 |
| Losartan-Hydrochlorothiazide | 17 | $626 | $37 |
| Hydrocodone-Acetaminophen | 22 | $549 | $25 |
| Hydralazine | 17 | $543 | $32 |
| Famotidine | 26 | $540 | $21 |
| Nabumetone | 13 | $530 | $41 |
| Ranitidine | 27 | $529 | $20 |
| Sertraline | 15 | $492 | $33 |
| Alendronate | 34 | $483 | $14 |
| Ibuprofen | 21 | $462 | $22 |
| Metoprolol | 48 | $456 | $9 |
| Montelukast | 18 | $449 | $25 |
| Lisinopril-Hydrochlorothiazide | 32 | $439 | $14 |
| Atenolol | 34 | $426 | $13 |
| Amlodipine Besylate | 42 | $348 | $8 |
| Furosemide | 31 | $345 | $11 |
| Baclofen | 11 | $329 | $30 |
| Fluticasone Propionate | 21 | $274 | $13 |
| Quetiapine | 18 | $239 | $13 |
| Hydrochlorothiazide | 21 | $238 | $11 |
| Doxycycline Monohydrate | 16 | $237 | $15 |
| Olopatadine | 11 | $231 | $21 |
| Prednisone | 13 | $192 | $15 |
| Sulfamethoxazole-Trimethoprim | 19 | $183 | $10 |
| Lovastatin | 15 | $182 | $12 |
| Cephalexin | 19 | $163 | $9 |
| Ciprofloxacin | 16 | $143 | $9 |
| Carvedilol | 12 | $140 | $12 |
| Fluoxetine | 12 | $132 | $11 |
| Trazodone | 12 | $120 | $10 |
| Amoxicillin | 12 | $111 | $9 |
| Ondansetron | 12 | $107 | $9 |
2016: 6 drugs
| Hydrocodone-Acetaminophen | 28 | $1,078 | $39 |
| Losartan | 13 | $384 | $30 |
| Simvastatin | 19 | $304 | $16 |
| Fluticasone Propionate | 11 | $145 | $13 |
| Meloxicam | 12 | $101 | $8 |
| Amlodipine Besylate | 16 | $69 | $4 |
2015: 14 drugs
| Proair Hfa | 29 | $1,483 | $51 |
| Doxycycline Hyclate | 30 | $1,333 | $44 |
| Fluticasone Propionate | 42 | $417 | $10 |
| Amoxicillin-Clavulanate Potass | 27 | $343 | $13 |
| Ciprofloxacin | 47 | $341 | $7 |
| Azithromycin | 38 | $302 | $8 |
| Nitrofurantoin Mono-Macro | 11 | $264 | $24 |
| Prednisone | 20 | $102 | $5 |
| Meloxicam | 19 | $102 | $5 |
| Sulfamethoxazole-Trimethoprim | 22 | $95 | $4 |
| Levofloxacin | 11 | $82 | $7 |
| Hydrocodone-Acetaminophen | 14 | $64 | $5 |
| Naproxen | 12 | $47 | $4 |
| Amlodipine Besylate | 11 | $31 | $3 |
2014: 21 drugs
| Doxycycline Hyclate | 25 | $1,403 | $56 |
| Proair Hfa | 20 | $979 | $49 |
| Nitrofurantoin Mono-Macro | 21 | $568 | $27 |
| Fluticasone Propionate | 35 | $537 | $15 |
| Ventolin Hfa | 11 | $497 | $45 |
| Ciprofloxacin | 58 | $327 | $6 |
| Sulfamethoxazole-Trimethoprim | 43 | $249 | $6 |
| Metronidazole | 12 | $205 | $17 |
| Amox Tr-Potassium Clavulanate | 13 | $194 | $15 |
| Hydrocodone-Acetaminophen | 20 | $171 | $9 |
| Gabapentin | 19 | $151 | $8 |
| Levofloxacin | 17 | $133 | $8 |
| Ondansetron | 11 | $118 | $11 |
| Amlodipine Besylate | 13 | $114 | $9 |
| Prednisone | 24 | $97 | $4 |
| Hydrochlorothiazide | 16 | $94 | $6 |
| Amoxicillin | 15 | $93 | $6 |
| Lisinopril | 18 | $90 | $5 |
| Cephalexin | 14 | $88 | $6 |
| Azithromycin | 11 | $83 | $8 |
| Simvastatin | 11 | $83 | $8 |
2013: 21 drugs
| Atorvastatin | 27 | $659 | $24 |
| Fluticasone Propionate | 23 | $571 | $25 |
| Voltaren | 14 | $548 | $39 |
| Metoprolol | 17 | $452 | $27 |
| Lisinopril | 52 | $312 | $6 |
| Metformin | 32 | $295 | $9 |
| Simvastatin | 27 | $263 | $10 |
| Amlodipine Besylate | 33 | $229 | $7 |
| Hydrochlorothiazide | 36 | $204 | $6 |
| Azithromycin | 11 | $172 | $16 |
| Meclizine | 13 | $152 | $12 |
| Ranitidine | 11 | $141 | $13 |
| Meloxicam | 21 | $134 | $6 |
| Furosemide | 27 | $130 | $5 |
| Sulfamethoxazole-Trimethoprim | 24 | $128 | $5 |
| Levofloxacin | 17 | $124 | $7 |
| Hydrocodone-Acetaminophen | 11 | $116 | $11 |
| Levothyroxine | 12 | $88 | $7 |
| Sertraline | 15 | $84 | $6 |
| Prednisone | 18 | $64 | $4 |
| Cephalexin | 11 | $58 | $5 |
Money from drug and device companies
$23 in 2024
| 2024 | 1 | 2 | None | $23 |
| 2022 | 2 | 2 | None | $39 |
| 2019 | 1 | 1 | None | $14 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Corium | Azstarys | $23 | 2 payments
|
See all 2 published payments
| Corium | Meals · 2024-11-21 | Azstarys | $4 |
| Corium | Meals · 2024-11-21 | Azstarys | $18 |
See earlier years (2022, 2019)
2022: $39
| Sanofi Pasteur | Vaxelis | $21 | 1 payment
|
| Cranial Technologies | Doc Band | $18 | 1 payment
|
2019: $14
| Boston Scientific | Watchman | $14 | 1 payment
|
Professional record
- NPI
- 1659513398
- Licence
- CA A123387California A123387: Current · expires 2028-07-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 1113 S Park Victoria Dr, Milpitas, CA, 95035
- NPI first listed
- 2009-03-26
- NPI last updated
- 2022-02-07
- NPI record certified
- 2022-02-07
This is when the NPI record was last certified, not a medical board exam.